已收盘 02-06 16:00:00 美东时间
+0.020
+0.01%
今日重点评级关注:RBC Capital:维持Compass Pathways"跑赢大市"评级,目标价从16美元升至21美元;RBC Capital:维持GH Research"跑赢大市"评级,目标价从33美元升至40美元
01-26 14:32
Oppenheimer analyst Noah Kaye maintains Waste Connections (NYSE:WCN) with a Outperform and lowers the price target from $206 to $205.
01-23 22:27
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从9美元升至50美元;韦德布什:维持Ardelyx, Inc."跑赢大市"评级,目标价从16美元升至19美元
01-22 15:09
今日重点评级关注:Guggenheim:维持MBX Biosciences"买入"评级,目标价从77美元升至88美元;摩根士丹利:维持DraftKings"超配"评级,目标价从50美元升至53美元
01-20 10:26
今日重点评级关注:HC Wainwright & Co.:维持Rezolve AI"买入"评级,目标价从10美元升至12美元;HC Wainwright & Co.:维持Largo"买入"评级,目标价从2.9美元升至3.1美元
01-15 16:10
JP Morgan analyst Tami Zakaria maintains Waste Connections (NYSE:WCN) with a Overweight and lowers the price target from $220 to $210.
01-15 03:36
今日重点评级关注:HC Wainwright & Co.:维持Assertio Holdings"买入"评级,目标价从3美元升至35美元;HC Wainwright & Co.:维持万达生物制药"买入"评级,目标价从20美元升至22美元
01-06 17:52
Bernstein analyst Connor Cerniglia maintains Waste Connections (NYSE:WCN) with a Outperform and raises the price target from $200 to $205.
01-05 22:14
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54
Morgan Stanley analyst Toni Kaplan maintains Waste Connections (NYSE:WCN) with a Overweight and raises the price target from $215 to $220.
2025-12-17 23:53